| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 05/14/2010 | CA2746054A1 Small molecule modulators of epigenetic regulation and their therapeutic applications |
| 05/14/2010 | CA2742980A1 Modulators of atp-binding cassette transporters |
| 05/14/2010 | CA2742910A1 Combinational therapy comprising dhodh inhibitor and methotrexate for treating autoimmune disease |
| 05/14/2010 | CA2742897A1 Modulators of amyloid beta. |
| 05/14/2010 | CA2742841A1 Treatment of restless leg syndrome and sleep disorders |
| 05/14/2010 | CA2742821A1 Modulators of atp-binding cassette transporters |
| 05/14/2010 | CA2742602A1 Gamma secretase modulators |
| 05/14/2010 | CA2742600A1 Leptin compositions and methods for treating progressive cognitive function disorders resulting from accumulation of neurofibrillary tangles and amlyoid beta |
| 05/14/2010 | CA2742500A1 Gamma secretase modulators |
| 05/14/2010 | CA2742317A1 Gamma secretase modulators |
| 05/14/2010 | CA2741500A1 Carbamate compound or salt thereof |
| 05/14/2010 | CA2741332A1 (pyrrolidin-2-yl)phenyl derivatives for use in the treatment of pain |
| 05/14/2010 | CA2741047A1 Novel compounds as cannabinoid receptor ligands |
| 05/14/2010 | CA2737393A1 Compositions and methods for minimizing or reversing agonist-induced desensitization |
| 05/13/2010 | US20100122362 Cells expressing alpha-synuclein and uses therefor |
| 05/13/2010 | US20100121061 Compounds capable of activating cholinergic receptors |
| 05/13/2010 | US20100120919 Methods for treating transthyretin amyloid diseases |
| 05/13/2010 | US20100120916 Therapeutic agent and diagnostic agent for mitochondrial dysfunction brain diseases |
| 05/13/2010 | US20100120912 Esters of capsaicinoids as dietary supplements |
| 05/13/2010 | US20100120909 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof |
| 05/13/2010 | US20100120906 Modified release formulation and methods of use |
| 05/13/2010 | US20100120900 Methods And Sequences To Preferentially Suppress Expression of Mutated Huntingtin |
| 05/13/2010 | US20100120887 Sustained release formulation of melatonin |
| 05/13/2010 | US20100120880 PROCESS TO PREPARE NEW SUBSITUTED 1H-BENZO[d]IMIDAZOL-2(3H)-ONES, NEW INTERMEDIATES AND THEIR USE AS BACE 1 INHIBITORS |
| 05/13/2010 | US20100120874 Heterocyclic gamma secretase modulators |
| 05/13/2010 | US20100120865 thiazol-2-yl-urea derivatives such as 3-{3-[4-Methyl-5-(4-pyrazol-1-yl-phenyl)-thiazol-2-yl]-ureido}-N-pyridin-3-yl-propionamide, used in the treatment of diseases ameloriated by inhibition of phosphatidylinositol 3-kinase, particularly inflammatory, allergic or autoimmune conditions |
| 05/13/2010 | US20100120864 2-aminooxazolines as taar1 ligands |
| 05/13/2010 | US20100120860 Thia(dia)zoles as fast dissociating dopamine 2 receptor antagonists |
| 05/13/2010 | US20100120859 Novel case of renin inhibitors |
| 05/13/2010 | US20100120857 Use of tris-quaternary ammonium salts as pain modulating agents |
| 05/13/2010 | US20100120852 Aroyl-piperidine derivatives and method of treating disorders induced by substance p |
| 05/13/2010 | US20100120850 Quinoline Derivatives, Pharmaceutical Compositions Comprising Them, and Their Use in Treating Central Nervous System and Peripheral Diseases |
| 05/13/2010 | US20100120842 Neurogenesis by muscarinic receptor modulation |
| 05/13/2010 | US20100120841 Benzimidazole compound and pharmaceutical use thereof |
| 05/13/2010 | US20100120839 Pyrazoles useful in the treatment of inflammation |
| 05/13/2010 | US20100120814 Crystalline and Amorphous Forms of Naltrexone Hydrochloride |
| 05/13/2010 | US20100120810 Compounds and methods for modulating rho gtpases |
| 05/13/2010 | US20100120809 Aryl heterocyclic cgrp receptor antagonists |
| 05/13/2010 | US20100120808 Spirocyclic heterocyclic derivatives and methods of their use |
| 05/13/2010 | US20100120807 Compounds and compositions as modulators of gpr119 activity |
| 05/13/2010 | US20100120806 Cyclopropane amides and analogs exhibiting anti-cancer and anti-proliferative activities |
| 05/13/2010 | US20100120803 3,4-dihydroquinazoline derivatives |
| 05/13/2010 | US20100120802 Novel Anti-Inflammatory and Analgesic Heterocyclic Amidines that Inhibit Nitrogen Oxide (NO) Production |
| 05/13/2010 | US20100120800 Agent for preventing recurrence of cerebrovascular disorder and agent for ameliorating troubles following cerebrovascular disorder and inhibiting progress thereof |
| 05/13/2010 | US20100120798 Substituted piperidines containing a heteroarylamide or heteroarylphenyl moiety |
| 05/13/2010 | US20100120793 Pyrrolidines |
| 05/13/2010 | US20100120792 Substituted 2,3,4,5-Tetrahyrdo-1H-Pyrido[4,3-B]Indoles, Methods for the Production and Use Thereof |
| 05/13/2010 | US20100120787 Modification of amyloid-beta load in non-brain tissue |
| 05/13/2010 | US20100120785 2-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-3-phenyl pyrazines and pyridines and 3-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-2-phenyl pyridines as 5-ht7 receptor antagonists |
| 05/13/2010 | US20100120784 Novel heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 05/13/2010 | US20100120779 1-(arylsulfonyl)-4-(piperazin-1-yl)-1h-benzimidazoles as 5-hydroxytryptamine-6 ligands |
| 05/13/2010 | US20100120778 Quinoxaline-based lxr modulators |
| 05/13/2010 | US20100120774 (2R,3 S)-3 ((2-chloro-4-pyrimidinyl)amino)-4-(3,5-difluorophenyl)-1 (((4'S)-6'-(2,2-dimethylpropyl)-3', 4'-dihydrospiro[cyclobutane-1,2'-pyrano[2,3-b]pyridin]-4'-yl)amino)-2-butanol, used for the treatment Alzheimer's disease, cognitive deficits and impairment, and schizophrenia |
| 05/13/2010 | US20100120769 Cyclohexyl piperazinyl methanone derivatives |
| 05/13/2010 | US20100120766 Substituted Pteridines |
| 05/13/2010 | US20100120762 Triazine derivatives as inhibitors of phosphodiesterases |
| 05/13/2010 | US20100120756 Phenothiazine modulators of h1 receptors |
| 05/13/2010 | US20100120755 Conjugated psychotropic drugs and uses thereof |
| 05/13/2010 | US20100120752 Muscarinic agonists to treat impulse control disorders |
| 05/13/2010 | US20100120747 Combination of a cholinesterase inhibitor and a compound with 5-ht6 receptor affinity |
| 05/13/2010 | US20100120746 Use of r-10-hydroxy-10,11-dihydro-carbamazepine in neuropathic pain |
| 05/13/2010 | US20100120744 Acetamidopropane modulators of nmda receptors |
| 05/13/2010 | US20100120738 Anti-apoptotic benzodiazepine receptor ligand inhibitors |
| 05/13/2010 | US20100120737 Amorphous ciclesonide |
| 05/13/2010 | US20100120731 3-([1,2,4]triazolo [4,3-a]pyridin-7-yl)benzamide derivatives |
| 05/13/2010 | US20100120725 Substituted Phenylsulfonamide Inhibitors of Beta Amyloid Production |
| 05/13/2010 | US20100120717 Kinase inhibitors |
| 05/13/2010 | US20100120705 Compositions and products containing s-equol, and methods for their making |
| 05/13/2010 | US20100120704 Cardiac glycosides to treat cystic fibrosis and other IL-8 dependent disorders |
| 05/13/2010 | US20100120696 Peptides Having Activities of Epidermal Growth Factor and Its Uses |
| 05/13/2010 | US20100120691 Neuregulins for prevention and treatment of damage from acute assault on vascular and neuronal tissue and as regulators of neuronal stem cell migration |
| 05/13/2010 | US20100120684 Mutants of interleukin- 1 receptor antagonist and uses thereof |
| 05/13/2010 | US20100120670 Cyclised alpha-conotoxin peptides |
| 05/13/2010 | US20100120669 Thiadiazole derivatives, inhibitors of stearoyl-coa desaturase |
| 05/13/2010 | US20100120660 Highly concentrated insulin solutions and compositions |
| 05/13/2010 | US20100120015 Method of collecting placental stem cells |
| 05/13/2010 | US20100119630 Valerian extract preparation |
| 05/13/2010 | US20100119624 Benzisoxazole modulators of d2 receptor and/or 5-ht2a receptor |
| 05/13/2010 | US20100119623 Imidazolyl modulators of 5-ht3 receptors |
| 05/13/2010 | US20100119622 3h-benzooxazol-2-one modulators of d2 receptor and/or 5-ht1a receptor |
| 05/13/2010 | US20100119607 Bioenhanced compositions |
| 05/13/2010 | US20100119601 Melatonin tablet and methods of preparation and use |
| 05/13/2010 | US20100119599 Polyhydroquinoline compounds and dihydropyridine compounds for inhibiting beta-amyloid production |
| 05/13/2010 | US20100119585 Transdermal therapeutic system for administering the active substance buprenorphine |
| 05/13/2010 | US20100119574 Recombinant Gelatins |
| 05/13/2010 | US20100119555 Methods and Compositions for the Treatment and Diagnosis of Cancer |
| 05/13/2010 | US20100119529 Elastin-like polymer delivery vehicles |
| 05/13/2010 | US20100119503 3-aminocyclopentanecarboxamides as modulators of chemokine receptors |
| 05/13/2010 | US20100119496 Adipose tissue derived stromal cells for the treatment of neurological disorders |
| 05/13/2010 | US20100119491 Dopaminergic neuronal survival-promoting factors and uses thereof |
| 05/13/2010 | US20100119475 Novel inhibitors of glutaminyl cyclase |
| 05/12/2010 | EP2184281A1 Phenyl-thiophene type vitamin D receptor modulators |
| 05/12/2010 | EP2184278A1 P2x4 receptor antagonist |
| 05/12/2010 | EP2184276A1 Process to prepare new substituted 1H-Benzo(d) imidazol-2(3h)-Ones, New intermediates and their use as bace 1 inhibitors |
| 05/12/2010 | EP2184272A1 Piperazine derivative |
| 05/12/2010 | EP2184085A1 Treatment of diseases |
| 05/12/2010 | EP2183258A2 Thiophosphi(o)nic acid derivatives and their use as agonists or antagonists for metabotropic glutamate receptors |
| 05/12/2010 | EP2183250A1 Naphthyridine derivatives as potassium channel modulators |
| 05/12/2010 | EP2183247A1 New crystalline forms of 2 -hydroxy- 3- ý5- (morpholin- 4- ylmethyl) pyridin-2-yl¨ih- indole- 5 -carbonitrile citrate |
| 05/12/2010 | EP2183246A2 2-aza-bicyclo-[3.3.0]-octane derivatives |